CBT for anxiety: new meta-analysis confirms significant improvements to target symptoms

CBT plus taper is effective at reducing benzodiazepine use in the short term (3 months) but this effect is not sustained at 6 months.

Inês Pote summarises a recent meta-analysis of randomised placebo-controlled trials of cognitive behavioural therapy for anxiety and related disorders.

[read the full story...]

IAPT: does improved access lead to increased complexity?

2701753359_1b8ef6a8d6_b

Mark Smith presents the early findings of the PROMPT naturalistic cohort study, which looks at the clinical characteristics of patients assessed within an Improving Access to Psychological Therapies (IAPT) service.

[read the full story...]

Psychiatric disorders: what’s the significance of non-random mating?

7960674098_2070f1fe64_b

Marcus Munafo considers the implications of a recent Swedish population study, which explores patterns of non-random mating within and across 11 major psychiatric disorders.

[read the full story...]

Lifetime prevalence of anxiety disorders in people with bipolar disorder

shutterstock_303720545

Alan Underwood appraises a recent meta-analysis that finds anxiety disorders are three times more common in people with a diagnosis of bipolar disorder.

[read the full story...]

Experience sampling and ecological momentary assessment for studying anxiety disorders

shutterstock_225033598

Alan Underwood publishes his debut Mental Elf blog on a narrative review of experience sampling and ecological momentary assessment for studying the lives of people with anxiety disorders.

[read the full story...]